Skip to main content
. 2020 Oct 9;8(2):e000948. doi: 10.1136/jitc-2020-000948

Figure 1.

Figure 1

US Food and Drug Administration approval of melanoma therapies.31 32 Agents shown are approved for metastatic melanoma unless stated and italicized. aFor patients whose tumors express BRAF V600E or V600K. bFor patients whose tumors express BRAF V600E.